The Sentinel GroupThe Sentinel Group Facebook ad: “Gabapentin & Lyrica Lawsuit Review”
Ran for 19 days, from March 3 to March 22, 2026, the last day Crush saw it.
Run by The Sentinel Group on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 1557155695348738
- Platforms
- Facebook, Instagram, Audience Network, Messenger and Threads
- Relaunches
- 2
Ad text
Memory loss before age 65 can be serious and deserves medical attention. Gabapentin, also known as Neurontin, and Lyrica, called pregabalin, have been prescribed for many conditions for more than two decades. Some patients now allege that repeated use may be associated with increased risk of early-onset dementia. If you were prescribed Gabapentin or Lyrica six or more times between 2000 and 2024 — for something other than nerve pain or seizures — and were later diagnosed by a neurologist with early-onset dementia before age 65, you may have legal options. Call The Sentinel Group now for a free, confidential case review.
Where the ad sends people
tsgtort.com
Gabapentin & Lyrica Lawsuit Review
Memory loss before age 65 may be serious. If you used Neurontin or Lyrica and were later diagnosed with dementia, contact The Sentinel Group.
Learn more: tsgtort.com(opens in a new tab)
